The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin Accumulation

Yue Lu, Linlin Meng, Xinlu Wang, Yun Zhang, Cheng Zhang, Meng ZhangInternational Journal of Molecular Sciences 2025 · DOI

TL;DR

This review highlights how mineral imbalances (calcium and phosphate) and the buildup of uremic toxins in chronic kidney disease (CKD) are major, often overlooked, drivers of cardiovascular disease (CVD). Understanding these non-traditional culprits is crucial for developing better treatments to improve the prognosis for CKD patients, who face a significantly higher risk of cardiovascular events.

What Problem Does This Paper Address?

Patients with chronic kidney disease (CKD) have a drastically elevated risk of dying from cardiovascular disease (CVD). While traditional risk factors like high blood pressure, diabetes, and high cholesterol are well-managed, a significant "residual risk" of life-threatening cardiovascular events persists. This paper addresses the critical need to understand and target the non-traditional factors contributing to this risk in CKD. Specifically, it focuses on how the kidneys' impaired ability to regulate minerals (calcium and phosphate) and clear waste products (uremic toxins) creates a toxic environment that directly damages the cardiovascular system, creating a vicious cycle that worsens both CKD and CVD.

Methods

This paper is a comprehensive review, not an experimental study. It synthesizes existing research from numerous scientific publications. The authors systematically reviewed literature to:

  • Elucidate pathophysiological connections: They explored the mechanisms by which mineral imbalances and uremic toxins impact cardiovascular health.
  • Identify key uremic toxins: The review focuses on specific dietary and gut-derived toxins like indoxyl sulfate, p-cresyl sulfate, trimethylamine N-oxide (TMAO), and asymmetric dimethylarginine (ADMA).
  • Analyze their impact: They detailed how these toxins contribute to processes like inflammation, oxidative stress, endothelial dysfunction, and vascular calcification.
  • Discuss therapeutic strategies: The authors reviewed current and proposed interventions for managing these toxins.

Datasets

Not applicable. This is a review article synthesizing existing research.

Key Insights and Ideas

  • CKD is a major independent risk factor for CVD: Even after accounting for traditional risk factors, CKD itself significantly increases the likelihood of cardiovascular events.
  • Mineral imbalance is a direct CVD driver: Dysregulation of calcium and phosphate doesn't just affect bones; it directly promotes vascular calcification, leading to stiffer arteries and higher blood pressure.
  • Uremic toxins are potent cardiovascular insults: Beyond just being waste products, toxins like indoxyl sulfate and TMAO actively promote inflammation, oxidative stress, and endothelial dysfunction, all hallmarks of cardiovascular disease.
  • Gut-kidney-heart axis is critical: The gut microbiome plays a significant role in producing many of these harmful uremic toxins, highlighting a complex interplay between gut health, kidney function, and cardiovascular outcomes.
  • Targeting non-traditional factors is essential: Managing only traditional risk factors is insufficient; interventions must address mineral balance and uremic toxin accumulation to truly reduce cardiovascular risk in CKD patients.

Key Results

The paper doesn't present new experimental results but synthesizes findings from numerous studies. Key takeaways include:

  • Vascular calcification mechanisms: High phosphate levels drive VSMC calcification via oxidative stress, osteogenic differentiation, and apoptosis. Elevated calcium acts as a nucleator.
  • Toxin-specific damage:
    • Indoxyl Sulfate (IS): Promotes endothelial dysfunction, oxidative stress, inflammation, and vascular calcification. It also contributes to CKD progression by damaging renal tubular cells.
  • P-Cresyl Sulfate (pCS): Similar to IS, it induces oxidative stress, inflammation, and endothelial dysfunction, and is linked to increased cardiovascular mortality.
  • TMAO: Associated with increased risk of CKD progression, cardiovascular events, vascular calcification, and cardiac dysfunction. It also promotes metabolic dysfunction.
  • ADMA: Inhibits nitric oxide production, leading to endothelial dysfunction, hypertension, and vascular calcification.
  • Therapeutic potential: Strategies like advanced dialysis membranes, oral adsorbents (e.g., AST-120), dietary modifications (protein and amino acid restriction), and modulation of gut microbiota (prebiotics/probiotics) show promise in reducing uremic toxin levels and their associated cardiovascular damage.

Limitations and Future Work

  • Understanding uremic toxin pathways: While many toxins are identified, their specific pathways and interactions are not fully elucidated, requiring further research.
  • Real-time monitoring: Current methods for detecting some highly toxic protein-bound uremic toxins (PBUTs) are not routine or real-time, hindering timely intervention.
  • Therapeutic efficacy and safety: While some strategies show promise, their long-term efficacy and safety in clinical practice need more robust investigation. Adsorbent therapies, for example, are not yet routinely applied.
  • Integration of strategies: Future work should focus on developing novel therapeutic strategies that simultaneously address mineral imbalances and uremic toxin effects, potentially through multi-organ protective interventions.
  • Collaborative research: Enhanced collaboration between nephrologists, cardiologists, and researchers is needed to improve diagnostic tools and therapeutic options for this complex CKD-CVD relationship.

Summary updated

Abstract

Chronic kidney disease (CKD) is associated with a significantly elevated mortality rate, primarily due to cardiovascular disease (CVD), highlighting a complex bidirectional relationship between the two conditions. Life-threatening cardiovascular events occur despite control of the traditional risk factors, emphasizing the underlying role of non-traditional risk factors. CKD, causing mineral imbalance and the accumulation of uremic toxins due to a compromised ability to excrete waste products, imposes extra pressure on the cardiovascular system. The retention of mineral and uremic toxins, in turn, aggravates the progression of CKD. This review aims to elucidate the pathophysiological connections between CKD and CVD, with a particular focus on the metabolic regulatory mechanisms influenced by minerals such as calcium and phosphate, as well as uremic toxins. We review how these factors contributed to accelerated multi-organ damage through mechanisms such as inflammation, endothelial dysfunction, oxidative stress, and vascular calcification. In addition, we discuss the therapeutic strategies for specific uremic toxins and proposed directions for future investigations. This review provides insights into the complex interplay between metabolic dysregulation and cardiovascular outcomes in CKD patients, promoting the development of innovative therapeutic interventions, ultimately improving the prognosis and quality of life for patients affected by these interconnected conditions.
BibTeX
@article{lu2025non,
  author = {Yue Lu and Linlin Meng and Xinlu Wang and Yun Zhang and Cheng Zhang and Meng Zhang},
  title = {{The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin Accumulation}},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167938},
}
Figure